Challenges and opportunities for oral pre-exposure prophylaxis in the prevention of HIV infection: where are we in Europe? (Q34968312)

5 August 2017

6 references

23 March 2019

22 June 2019

19 October 2019

26 April 2020

18 December 2020

25 October 2022

Challenges and opportunities for oral pre-exposure prophylaxis in the prevention of HIV infection: where are we in Europe? (English)

1 reference

human immunodeficiency virus infectious disease

5 August 2017

main subject

prevention of HIV/AIDS

0 references

5 references

23 March 2019

22 June 2019

19 October 2019

26 April 2020

1 July 2020

Retroviridae infectious disease

1 reference

PubMed

RNA virus infectious disease

19 October 2019

1 reference

1 July 2020

1 reference

18 December 2020

8

Constance Delaugerre

1 reference

5 August 2017

1

Jean-Michel Molina

1 reference

5 August 2017

Claire Pintado

2

1 reference

5 August 2017

Caroline Gatey

3

1 reference

5 August 2017

Diane Ponscarme

4

1 reference

5 August 2017

Pierre Charbonneau

5

1 reference

5 August 2017

Benedicte Loze

6

1 reference

5 August 2017

Willy Rozenbaum

7

1 reference

5 August 2017

language of work or name

English

0 references

publication date

23 August 2013

8 references

5 August 2017

23 March 2019

22 June 2019

19 October 2019

26 April 2020

1 July 2020

18 December 2020

25 October 2022

8 references

5 August 2017

23 March 2019

22 June 2019

19 October 2019

26 April 2020

1 July 2020

18 December 2020

25 October 2022

11

1 reference

5 August 2017

page(s)

186

1 reference

Creative Commons Attribution

5 August 2017

copyright license

7 references

23 March 2019

22 June 2019

19 October 2019

26 April 2020

1 July 2020

18 December 2020

25 October 2022

0 references

on focus list of Wikimedia project

ScienceSource

0 references

cites work

The acceptability and feasibility of an HIV preexposure prophylaxis (PrEP) trial with young men who have sex with men.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3751938

Antiretroviral prophylaxis for HIV infection in injecting drug users in Bangkok, Thailand (the Bangkok Tenofovir Study): a randomised, double-blind, placebo-controlled phase 3 trial

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3751938

HIV incidence in men who have sex with men in England and Wales 2001-10: a nationwide population study.

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3751938

Simultaneous analysis of antiretroviral drugs abacavir and tenofovir in human hair by liquid chromatography-tandem mass spectrometry.

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3751938

The potential impact of pre-exposure prophylaxis for HIV prevention among men who have sex with men and transwomen in Lima, Peru: a mathematical modelling study

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3751938

Emtricitabine-tenofovir concentrations and pre-exposure prophylaxis efficacy in men who have sex with men.

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3751938

Tenofovir, emtricitabine, and tenofovir diphosphate in dried blood spots for determining recent and cumulative drug exposure

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3751938

Preexposure prophylaxis for HIV infection among African women

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3751938

Antiretroviral preexposure prophylaxis for heterosexual HIV transmission in Botswana

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3751938

Antiretroviral prophylaxis for HIV prevention in heterosexual men and women

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3751938

Biomarker-based HIV incidence in a community sample of men who have sex with men in Paris, France

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3751938

Sexual frequency and planning among at-risk men who have sex with men in the United States: implications for event-based intermittent pre-exposure prophylaxis

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3751938

Symptomatic vaginal discharge is a poor predictor of sexually transmitted infections and genital tract inflammation in high-risk women in South Africa

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3751938

The cost-effectiveness of preexposure prophylaxis for HIV prevention in the United States in men who have sex with men.

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3751938

Limited Awareness and Low Immediate Uptake of Pre-Exposure Prophylaxis among Men Who Have Sex with Men Using an Internet Social Networking Site

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3751938

What's love got to do with it? Explaining adherence to oral antiretroviral pre-exposure prophylaxis for HIV-serodiscordant couples

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3751938

Determinants of per-coital-act HIV-1 infectivity among African HIV-1-serodiscordant couples

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3751938

Penetration of tenofovir and emtricitabine in mucosal tissues: implications for prevention of HIV-1 transmission

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3751938

Acceptability of an "on-demand" pre-exposure HIV prophylaxis trial among men who have sex with men living in France

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3751938

Bone mineral density in HIV-negative men participating in a tenofovir pre-exposure prophylaxis randomized clinical trial in San Francisco

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3751938

Preexposure Chemoprophylaxis for HIV Prevention in Men Who Have Sex with Men

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3751938

Population-based HIV-1 incidence in France, 2003-08: a modelling analysis.

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3751938

Sensitivity of five rapid HIV tests on oral fluid or finger-stick whole blood: a real-time comparison in a healthcare setting

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3751938

Effectiveness and safety of tenofovir gel, an antiretroviral microbicide, for the prevention of HIV infection in women

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3751938

Pharmacokinetics and disposition of rilpivirine (TMC278) nanosuspension as a long-acting injectable antiretroviral formulation

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3751938

Clinical decisions. Preexposure prophylaxis for HIV prevention--polling results

8 July 2018

1 reference

https://api.crossref.org/works/10.1186%2F1741-7015-11-186

How good is "good enough"? The case for varying standards of evidence according to need for new interventions in HIV prevention

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1741-7015-11-186

Screening for, monitoring, and treatment of chronic kidney disease stages 1 to 3: a systematic review for the U.S. Preventive Services Task Force and for an American College of Physicians Clinical Practice Guideline

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1741-7015-11-186

Intermittent prophylaxis with oral truvada protects macaques from rectal SHIV infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1741-7015-11-186

The British HIV Association/British Association for Sexual Health and HIV Position Statement on pre-exposure prophylaxis in the UK

21 January 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/23972284

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Compliancy of pre-exposure prophylaxis for HIV infection in men who have sex with men in Chengdu

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/23972284

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1186/1741-7015-11-186

1 reference

Dimensions Publication ID

5 August 2017

0 references

1 reference

5 August 2017

1 reference